rs3785883 — MAPT H1h Sub-haplotype Tag

MAPT H1h — The Sub-haplotype Connecting Tau to Parkinson's Motor Phenotype

The MAPT gene encodes tau, a microtubule-stabilising protein central to several neurodegenerative diseases. The gene sits within a large chromosomal inversion on 17q21 that divides all humans into two broad haplotype clades: H1 (no inversion) and H2 (inverted). H1 carriers face elevated tau-related disease risk — but H1 is not a single entity. It encompasses a family of sub-haplotypes, each defined by a unique combination of alleles at six tagging positions. rs3785883 defines the H1h sub-haplotype, a configuration that carries a distinctive risk profile separate from the well-characterised H1c sub-haplotype tracked by rs242557 and rs2471738.

The Mechanism

The rs3785883 A allele co-occurs with rs242557 G and rs2471738 C to form the H1h sub-haplotype (full composition: rs1467967=A, rs242557=G, rs3785883=A, rs2471738=C). This is structurally distinct from H1c (rs242557=A, rs2471738=T, rs3785883=G): the two sub-haplotypes carry the A allele at rs3785883 and rs242557 in opposite orientations. The linkage disequilibrium between rs3785883 and rs242557 is extremely low¹¹ extremely low
r² ≈ 0.01 measured in both healthy controls and PSP patients, confirming these SNPs are statistically and biologically independent.

The molecular consequence of the H1h configuration is not fully characterised, but the sub-haplotype pattern implicates altered tau isoform ratios or expression levels in neurons within specific motor circuits. The non-tremor dominant (NTD) phenotype of Parkinson's disease — characterised by postural instability and gait difficulty rather than resting tremor — is the clinical domain where H1h risk concentrates, suggesting a preferential effect on basal ganglia circuitry.

The Evidence

A 2016 study examining MAPT subhaplotype architecture across PD subtypes²² MAPT subhaplotype architecture across PD subtypes
Ezquerra et al. Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes. Front Cell Neurosci, 2016 found that the H1h sub-haplotype was overrepresented in NTD-PD patients compared with controls with an OR of 2.9 (95% CI 1.3–6.3) that survived Bonferroni correction (p = 0.007). The overall PD association (uncorrected OR 2.6, p = 0.013) did not reach significance after correction. At the individual-SNP level, rs3785883 showed a nominally significant association with NTD-PD (OR 1.5, p = 0.044) that did not survive multiple-testing correction — the haplotype-level signal is stronger than the single-SNP signal, consistent with the variant acting as part of a combinatorial genetic background rather than as an independent causal allele.

Earlier subhaplotype work (Goris et al., 2007)³³ (Goris et al., 2007) established the key contrast: rs242557 (H1c) does not alter PD risk, while rs3785883 participates in a sub-haplotype block that does — precisely the opposite of the PSP/CBD pattern, where H1c dominates. This disease-specific partitioning of H1 sub-haplotype risk is a central insight of MAPT genetic architecture.

A Croatian cohort study of Alzheimer's disease biomarkers found both AA and GG genotypes at rs3785883 associated with pathological CSF and plasma biomarkers, though the authors noted the interpretation is ambiguous and flagged it for further investigation. A meta-analysis of MAPT variants in neurodegenerative diseases found only a nominally protective A-allele signal in Caucasians (OR 0.87) that disappeared after sensitivity analysis, providing no reliable AD risk signal for this SNP.

The overall evidence level is moderate: the H1h-NTD-PD association is supported by a single well-designed study with correction for multiple testing, but has not yet been replicated in independent cohorts. The AD biomarker data are preliminary and contradictory.

Practical Actions

Carriers of the A allele — particularly those homozygous AA — exist within the H1h sub-haplotype background and face modestly elevated risk for the akinetic-rigid/postural- instability variant of Parkinson's disease. The actionable implications are similar to other MAPT risk variants: prioritising cardiovascular and metabolic health (which modifies the timing and severity of tau-related neurodegeneration), regular monitoring for early motor symptoms, and physical activity targeting balance and postural stability. Aerobic exercise has been shown to promote tau clearance via glymphatic pathways and reduce neuroinflammation, making it particularly relevant here.

Interactions

rs3785883 (H1h) and rs242557 (H1c) are nearly independent (r² ≈ 0.01) and tag distinct disease risks: H1h → NTD-PD, H1c → PSP/CBD. An individual who carries the A allele at rs3785883 is unlikely to also carry the A allele at rs242557 on the same chromosomal background. Compound analysis of all six MAPT tagging positions (rs1467967, rs242557, rs3785883, rs2471738, del-In9, rs7521) provides the most complete sub-haplotype picture. rs17651213 (exon 3 splice regulator) adds a mechanistic layer: its G allele elevates 4-repeat tau isoforms across most H1 sub-haplotypes including H1h, potentially amplifying the H1h motor risk signal.